Increased serum levels of AngII have been reported in large groups of patients with hypertension-associated cardiovascular diseases, and have been proven to be potent pro-fibrotic molecules by activating the TGFβ signaling pathway and exacerbating EndoMT [65, 66]. Here, TGFB1 is linked to hypertensive disorder.